Search research articles
Contact Us
Filters
Showing results (181-190 of 234) with videos related to
Page
of 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2019
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
David M Cordas Dos Santos, Rima M Saliba, Romil Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
Simrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 31, 2012
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies
Yago Nieto, Peter Thall, Ben Valdez, et al.
Transfusion
|
October 15, 2013
Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers
Chitra Hosing, Rima M Saliba, Nelson Hamerschlak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 5, 2018
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
Yago Nieto, Peter F Thall, Junsheng Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial
Uday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Bone Marrow Transplantation
|
October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Transplantation and Cellular Therapy
|
February 8, 2025
Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality
Mansour Alkhunaizi, Felipe Soto-Lanza, Cheuk Hong Leung, et al.
Haematologica
|
February 20, 2025
A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome
Ian M Bouligny, Guillermo Montalban-Bravo, Koji Sasaki, et al.
Transplantation and Cellular Therapy
|
May 26, 2022
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes
Gheath Alatrash, Chantal Saberian, Roland Bassett, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 234) with videos related to
Sort By:
Page
of 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2019
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
David M Cordas Dos Santos, Rima M Saliba, Romil Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
Simrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 31, 2012
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies
Yago Nieto, Peter Thall, Ben Valdez, et al.
Transfusion
|
October 15, 2013
Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers
Chitra Hosing, Rima M Saliba, Nelson Hamerschlak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 5, 2018
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
Yago Nieto, Peter F Thall, Junsheng Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial
Uday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Bone Marrow Transplantation
|
October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Transplantation and Cellular Therapy
|
February 8, 2025
Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality
Mansour Alkhunaizi, Felipe Soto-Lanza, Cheuk Hong Leung, et al.
Haematologica
|
February 20, 2025
A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome
Ian M Bouligny, Guillermo Montalban-Bravo, Koji Sasaki, et al.
Transplantation and Cellular Therapy
|
May 26, 2022
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes
Gheath Alatrash, Chantal Saberian, Roland Bassett, et al.
Page
of 24